Clinical trial

Schizophrenia Trial of Aripiprazole

NCT00237913

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-07-01

PhasePHASE3

Study timeline

Study start (unknown)2004-07-01Date precision: month

Registry last updated2013-11-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

AripiprazoleDRUG · verified · RxNorm: aripiprazole

Olanzapine or Quetiapine or RisperidoneDRUG

Sponsors & collaborators

Otsuka Pharmaceutical Development & Commercialization, Inc.lead sponsor

Otsuka America Pharmaceuticalcollaborator

Mapped research locations

ParisFrance1 ToulouseFrance1 ViennaAustria1 MünchenGermany1 RennesFrance1 CopenhagenDenmark1 HelsinkiFinland1 ReimsFrance1 MalmöSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00237913 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.